AstraZeneca
investing to unlock next waves of innovation committed to science led innovation small molecules cell based therapy car antibodies cell nucleotide based conjugates peptide protein therapeutics in expressed high impact journal manuscripts published total journal publications regulatory designations | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
February 2023
Slide
7 of 45
Related slides by other companies
Orbia
Investor Day
May 2022
investing in growth and innovation | Orbia
Orbia
Investor Day
May 2022
investing in growth and innovation | Orbia
Orbia
Investor Day
May 2022
investing in growth and innovation | Orbia
Orbia
Investor Day
May 2022
investing in growth and innovation | Orbia
Other recent decks by AstraZeneca
See all presentations (27 decks)
Results
February 2024
Investor Conference
January 2024
Results
November 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io